Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  BIOYF

Biosyent Inc is a life science company engaged in marketing of pharmaceutical products & manufacturing & marketing of non-chemical bio & health-friendly insecticides. It acquires or license products & commercializes technology to health & public safety.
Price: $7.35 | Change: +$0.08 | %Change: +1.10%
Volume: 17,070 | Day High/Low: 7.45/7.26 | 52 Week High/Low: 12.82/6.54
View modes: 
1 star

Artificially low

I find that the stock price is artificially low. I bet the ownership is manipulating the stock price before the Q2 results come out (with huge improvements) so they can make more money. more
1.5 stars


For those who haven't seen it; first stock in the clip. Like others, he is waiting for them to expand their product line. GLTA more
0 stars

RE:RE:RE:RE:RE:Donville on BNN Market Call Tomorrow

Sounds like "Professional" market makers could be working this stock, to help drive the price down. Reason??  rate and reply
0 stars

RE:RE:RE:RE:Donville on BNN Market Call Tomorrow

Donville definitely manipulates prices of stocks he is recommending. I know, it makes sense to listen to what he is saying as a starting point for analysis, but serious investor should not more
0 stars

RE:RE:RE:Donville on BNN Market Call Tomorrow

I don't think it was much of a recommendation; he was very muted. --made no mention that it was a TOP PICK at a higher price just a few weeks ago. I know I cxld my plan to buy more, should more
0 stars

RE:RE:Donville on BNN Market Call Tomorrow

I go for a run after reporting that Donville recommended RX, come back and the SP is $0.50 lower than when I left because someone decides to sell their stock for $7.20. Who are these people? LOL  rate and reply
0 stars

RE:Donville on BNN Market Call Tomorrow

He did not cover Cipher or Merus, recommended Biosyent, PHM and Nobilus and made CRH a top pick.  GLTA  rate and reply
3 stars

Would the Aequitas NEO Exchange ....

be a better fit for Biosyent? Share price has fallen from $12.82 to todays close of $7.59 on the Venture! The Venture as a whole sits at 667.09 a mere 40 points from its all time low! From $ more
0 stars

Donville on BNN Market Call Tomorrow

So what healthcare/pharma company will he be in favour of - Biosyent, Cipher, Patient Home, CRH, Nobilis, Merus???  rate and reply
0 stars

Q2 is almost in the books

Going back to 2010 (prior numbers are too small to be meaningful), RX's sequential pharma revenue growth (that is, any one quarter over the immediately preceding quarter) has always been highest in more
3 stars

RE:" Lets Make It A Level Playing Field For Everyone....

CORRECTION LINK: Cheers!  rate and reply
1 star

" Lets Make It A Level Playing Field For Everyone....

that is going to participate" said Greg Mills,Equitas Neo Exchange Chairman. Three goals of the New Equitas Neo Exchange (NEO): Link: Cheers!  rate and reply
1 star

RE:Others are making the move.....

Unlike you, the management has other things on their mind besides motives to push up their share price.  Your greed is beyond idiocy.  Keep flogging .    Cheers! Buy low Sell High--- Why didn't more
0 stars

RE:Others are making the move.....

Well, someone should grow up, but it's not Biosyent. Over the past 3 years, its price has gone from about $.58 to $8.06 on the Venture Exchange. Good companies will attract good prices, period.  rate and reply
3 stars

Others are making the move.....

When will Biosyent grow up and move to a Sr. Exchange or is management content to watch its market cap diminish??? Cheers!  rate and reply
1 star

RE:Convalo Health International Corp To Uplist....

TOO small to move  rate and reply
3 stars

Convalo Health International Corp To Uplist....

Michael Dalsin, CEO and Chairman; " Convalo is growing much more quickly than we initially anticipated. We have grown our business from about $5 million annual revenue business with $1 million more
1 star

RE:RE:Todays trade.

Jun 15/15 Jun 15/15 Wakefield, Milt Direct Ownership Common Shares 10 - Disposition in the public market -4,000 $8.01 From more
1 star

RE:Todays trade.

Those 4,000 shares were those of an insider according to today`s TMX insider trading data.  rate and reply
0 stars

Todays trade.

At 7:30 today some one entered a SELL of 4000 shares at 7.85 when the bid before that was 8.40. That trade eventually filled at the bell at $8:01. That caused panic when there is very little more